Chiusura precedente | 0,00 |
Aperto | 0,00 |
Denaro | N/D x N/D |
Lettera | N/D x N/D |
Min-Max giorno | 0,00 - 0,00 |
Intervallo di 52 settimane | |
Volume | |
Media Volume | 11 |
Capitalizzazione | N/D |
Beta (5 anni mensile) | 0,14 |
Rapporto PE (ttm) | N/D |
EPS (ttm) | N/D |
Prossima data utili | N/D |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | N/D |
PRESS RELEASE Paris, 23rd August 2023 Provisional annual results at the end of June 2023 Group revenue increased by 9.3% to €4.7bn supported by positive activity volume growth in all geographies and recent acquisitions in the Nordic countries. Revenue growth on a like-for-like basis of 7.0%. Group EBITDA decreased by 5.6% to €621.4m, impacted by lower subsidies, high salary and procurement inflation and staff shortage challenges. Group share of net result after tax of €49.4m or 1.1% of revenue m
PRESS RELEASEParis, 2 May 2023 13.5% total revenues growth for the third quarter of this financial year, up to €1.3bn total revenues, supported by a broad-based good dynamics and recent acquisitions in the Nordics countries. Growth on a like-for-like basis of 10.2%. Continuously playing a leading role in addressing the numerous headwinds impacting the healthcare sector in Europe. For the quarter, EBITDA decreased by €30m leading to €137m and 11.0% margin for this quarter, due to lower subsidies,